2011
DOI: 10.1016/j.lfs.2011.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-6 plays a protective role in development of cisplatin-induced acute renal failure through upregulation of anti-oxidative stress factors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
19
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(20 citation statements)
references
References 39 publications
1
19
0
Order By: Relevance
“…In a previous study, increased MPO activity and inflammation (infiltration of leukocytes and proinflammatory cytokines) caused oxidative stress and tissue damage in cisplatin-induced acute renal injury. 47 In our experiment, reduced kidney MPO activity after MSC injection indicated a possible decrease in neutrophil accumulation or activity. This finding indicates that MSCs could be a therapeutic approach as a potent immunosuppressive for the attenuation of histopathologic signs of UUO.…”
Section: Discussionsupporting
confidence: 52%
“…In a previous study, increased MPO activity and inflammation (infiltration of leukocytes and proinflammatory cytokines) caused oxidative stress and tissue damage in cisplatin-induced acute renal injury. 47 In our experiment, reduced kidney MPO activity after MSC injection indicated a possible decrease in neutrophil accumulation or activity. This finding indicates that MSCs could be a therapeutic approach as a potent immunosuppressive for the attenuation of histopathologic signs of UUO.…”
Section: Discussionsupporting
confidence: 52%
“…In one study, they showed that IL-6 levels were increased in proximal tubular cells after cisplatin treatment and that IL-6 knockout (IL-6 −/− ) mice presented more severe AKI with Bax followed by an increase in Bcl-2 and Bcl-xL [15] . This same group demonstrated that IL-6 −/− mice showed more oxidative stress with increased cox-2 expression and ERK phosphorylation, while superoxide dismutase activity was decreased [14] . More recently, the use of dimethylthiourea (DMTU), a hydroxyl radical scavenger, was shown to protect mice from cisplatin-induced AKI by increasing IL-6, Bcl-xL and Nrf2 [13] .…”
Section: Discussionmentioning
confidence: 81%
“…IL-6 KO mice are resistant to HgCl 2 -induced AKI, yet IL-6 trans-signaling prevents AKI perhaps due to upregulation of anti-oxidant pathways [50]. IL-6 deficiency also accelerates cisplatin-induced AKI [56], and investigators have proposed that IL-6 may be protective in ischemic renal failure and in a mouse model of rhabdomyolysis-induced AKI [57,58]. These variable outcomes in IL-6 KO mice could be due to the doses of injurious factors, experimental time course and definitions of AKI.…”
Section: Discussionmentioning
confidence: 99%